Market Cap 75.54M
Revenue (ttm) 0.00
Net Income (ttm) -11.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 85,400
Avg Vol 1,189,350
Day's Range N/A - N/A
Shares Out 49.05M
Stochastic %K 73%
Beta 0.50
Analysts Strong Sell
Price Target $7.00

Company Profile

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical my...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 373 1500
Fax: 858 404 0048
Address:
4275 Executive Square, Suite 300, La Jolla, United States
thepalace2007
thepalace2007 Nov. 13 at 1:19 AM
$MNOV keep accumulating this will fly with news on earnings
1 · Reply
Zackpedia
Zackpedia Nov. 12 at 8:15 PM
0 · Reply
Hanmer
Hanmer Nov. 10 at 3:28 PM
$MNOV this one is ready to launch!!!!
0 · Reply
Zackpedia
Zackpedia Nov. 7 at 6:02 PM
$MNOV You could’ve sold when I alerted and bought back at 1.4 now if you wanted, hit Follow and subscribe to get my alerts on time and make money
0 · Reply
Hanmer
Hanmer Nov. 7 at 1:35 PM
$MNOV we were over $1.60 this morning premarket already!!!
1 · Reply
Stackingg
Stackingg Nov. 7 at 1:34 PM
0 · Reply
TCzeck
TCzeck Nov. 7 at 5:38 AM
$MNOV BOOM!
0 · Reply
Hanmer
Hanmer Nov. 7 at 2:11 AM
$MNOV she’s looking sexy tonight!!!
0 · Reply
Lionish
Lionish Nov. 7 at 12:11 AM
$MNOV Up over 20% again in Tokyo now
0 · Reply
thepalace2007
thepalace2007 Nov. 6 at 11:38 PM
$MNOV big money is loading and so should you $6+ coming soon
0 · Reply
Latest News on MNOV
MediciNova Provides Shareholder Update on Key Developments

Sep 8, 2025, 9:00 AM EDT - 2 months ago

MediciNova Provides Shareholder Update on Key Developments


MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial

Aug 26, 2025, 7:00 PM EDT - 2 months ago

MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial


MediciNova Chief Business Officer David H. Crean, Ph.D.

Jun 20, 2024, 6:00 AM EDT - 1 year ago

MediciNova Chief Business Officer David H. Crean, Ph.D.


MediciNova Receives Gene Therapy Milestone Payment

Oct 4, 2023, 7:00 PM EDT - 2 years ago

MediciNova Receives Gene Therapy Milestone Payment


thepalace2007
thepalace2007 Nov. 13 at 1:19 AM
$MNOV keep accumulating this will fly with news on earnings
1 · Reply
Zackpedia
Zackpedia Nov. 12 at 8:15 PM
0 · Reply
Hanmer
Hanmer Nov. 10 at 3:28 PM
$MNOV this one is ready to launch!!!!
0 · Reply
Zackpedia
Zackpedia Nov. 7 at 6:02 PM
$MNOV You could’ve sold when I alerted and bought back at 1.4 now if you wanted, hit Follow and subscribe to get my alerts on time and make money
0 · Reply
Hanmer
Hanmer Nov. 7 at 1:35 PM
$MNOV we were over $1.60 this morning premarket already!!!
1 · Reply
Stackingg
Stackingg Nov. 7 at 1:34 PM
0 · Reply
TCzeck
TCzeck Nov. 7 at 5:38 AM
$MNOV BOOM!
0 · Reply
Hanmer
Hanmer Nov. 7 at 2:11 AM
$MNOV she’s looking sexy tonight!!!
0 · Reply
Lionish
Lionish Nov. 7 at 12:11 AM
$MNOV Up over 20% again in Tokyo now
0 · Reply
thepalace2007
thepalace2007 Nov. 6 at 11:38 PM
$MNOV big money is loading and so should you $6+ coming soon
0 · Reply
Hanmer
Hanmer Nov. 6 at 11:03 PM
$MNOV sky rockets in flight, afternoon delight!!!!
0 · Reply
Achila2018
Achila2018 Nov. 5 at 9:02 PM
$MNOV moving sideways ... hmmm
0 · Reply
Hanmer
Hanmer Nov. 5 at 2:55 AM
$MNOV I’m loving the overnight trading up 18%!!!
0 · Reply
scubarat
scubarat Nov. 4 at 2:47 PM
$MNOV when a company pays to publish the same exact news twice in 5 days, that doesn’t look good. 10/31 and today 11/4 they publish news of their $9 price target. In other words, these guys are pumping so be ready for a quick offering from them the first big day they have again.
1 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 1:40 PM
D. Boral Capital has adjusted their stance on MediciNova ( $MNOV ), setting the rating to Buy with a target price of 9.
0 · Reply
drwaz
drwaz Nov. 4 at 12:38 PM
$MNOV 👀
0 · Reply
bowlerhatsftw
bowlerhatsftw Nov. 4 at 3:30 AM
$MNOV Level/Action Entry Zone $1.48–$1.52 (shelf bounce) or $1.55+ with reclaim + OBV push Stop Loss Close below $1.44 (breaks shelf structure) Target 1 $1.61–$1.64 (VWAP + Fib bounce zone) Target 2 $1.72 (shelf re-tap + minor dark pool print) Target 3 $1.88 (macro swing fade area) 📌 Volume must confirm breakout past $1.59 — otherwise, this stalls into another round of absorption. 📊 Probability BreakdoWn Scenario Outcome Probability ✅ Shelf Hold + OBV Push → Break $1.59 → $1.64+ 65% 🔁 Chop Between $1.47–$1.57 20% ⚠️ Breakdown below $1.44 (invalidates) 10% 🚨 Full Exit + Fade Back to $1.32 5%
0 · Reply
Zackpedia
Zackpedia Nov. 3 at 10:40 PM
$MNOV You could’ve sold when I alerted and bought back at 1.46 now if you wanted, hit Follow and subscribe to get my alerts on time and make money
0 · Reply
Lionish
Lionish Nov. 3 at 9:51 PM
$MNOV Hang in there! I still see a bright future in Medicinova. Unlike other biotech, there is much less surprise and risk since MNOV is focusing on drug repositioning. We already know the side effects and adverse effects even if there are any.
0 · Reply
Nolanmp26
Nolanmp26 Nov. 3 at 2:46 PM
$MNOV Slap that ask over $1.55
0 · Reply
doledav
doledav Nov. 3 at 2:40 PM
$MNOV shorts hitting it hard
0 · Reply
TCzeck
TCzeck Nov. 3 at 1:32 PM
$MNOV Let's see them $2's this week! Great company, happy to be part of it for the long journey!
0 · Reply